GlaxoSmithKline (GSK) announces that the EMA's Committee for Medicinal Products for Human Use ((CHMP)) has issued positive opinions recommending Nucala (mepolizumab) for use in...
Merck & Co. Inc. said it expects the company's experimental oral antiviral treatment for COVID-19 could get emergency authorization by the end of the year. "We expect to be able...
There's no better time than now to invest in dividend stocks. And some of the best dividend stocks that beat the S&P 500's average yield of 2% can be found in the healthcare...
There are several well-known large-cap stocks going ex-dividend next week.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Sell | Strong Sell | Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Buy |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 175.92 | 179.66 | 175.48 | -6.80 | -3.72% | 17.11M | London | |||
| 300.96 | 303.25 | 299.70 | -3.70 | -1.22% | 10.90M | London | |||
| 5.85 | 5.90 | 5.90 | -0.07 | -1.26% | 1.02M | London | |||
| 3,984.00 | 4,056.00 | 3,984.00 | -93.0 | -2.28% | 65.27K | London | |||
| 726.40 | 734.80 | 724.20 | -3.80 | -0.52% | 453.54K | London | |||
| 48.49 | 49.19 | 48.36 | -0.92 | -1.86% | 2.75M | London | |||
| 1,781.20 | 1,836.80 | 1,774.60 | -92.60 | -4.94% | 3.16M | London | |||
| 366.95 | 370.95 | 364.80 | -9.10 | -2.42% | 10.03M | London | |||
| 2,807.78 | 2,821.84 | 2,780.46 | -4.22 | -0.15% | 9.27K | London | |||
| 545.10 | 550.00 | 546.00 | -10.00 | -1.82% | 68.81K | London | |||
| 113.78 | 114.32 | 112.82 | -0.54 | -0.47% | 13.74M | London | |||
| 50.34 | 51.20 | 50.10 | -0.74 | -1.45% | 3.03M | London | |||
| 2,634.50 | 2,657.00 | 2,619.00 | -24.5 | -0.92% | 590.09K | London | |||
| 419.90 | 435.40 | 419.40 | -22.10 | -5.00% | 2.81M | London | |||
| 661.50 | 670.50 | 647.50 | +5.00 | +0.76% | 182.40K | London |
GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.